Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Levmentin
- Development stage
- Phase 4
- Lead developer
- Delbert Pharma
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Levmentin is a marketed intravenous antibiotic combination developed by Delbert Pharma, consisting of amoxicillin, a beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor. It is primarily indicated for the treatment of severe bacterial infections, including those in the respiratory tract and pneumology. Amoxicillin works by inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), while clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria. Delbert Pharma specializes in maintaining essential medicines, and Levmentin is provided as a powder for solution for injection or infusion in various dosage strengths.
- Brand names
- Levmentin
- Other names
- amoxicillin + clavulanic acid
02
Targets
PBP (Penicillin-binding protein family)Neuraminidaseβ-lactamase
Beyond the preview
Go deeper on Levmentin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Levmentin.